Oral medicinal forms with reproducible release of the active ingr edient gatifloxacin or its pharmaceutically acceptable salts or hydrates
CA 2325636 A1 · Owner: Kyorin Pharmaceutical Co. Ltd. · Inventors: Bartholomaus, Johannes; Betzing, Jurgen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to solid medicinal preparations having a multiphase structure for oral administration, which contain gatifloxacin or pharmaceutically suitable salts or hydrates thereof as well as additives from , the group including fillers binding agents, lubricants, disintegrating agents or mixtures thereof. The inner phase contains the active ingredient gatifloxacin or pharmaceutically suitable salts or hydrates thereof additives , from the group including binding agents fillers, disintegrating agents or , mixtures thereof and at least one outer phase consists of at least one disintegrating agent as well as other additives selected from a group containing at least one …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 29, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 29, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 29, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.